Journal of Medicinal Chemistry
Article
therapeutic strategy. MedChemComm 2012, 3 (2), 123−134. (b) Fili-
ppakopoulos, P.; Picaud, S.; Mangos, M.; Keates, T.; Lambert, J. P.;
Barsyte-Lovejoy, D.; Felletar, I.; Volkmer, R.; Muller, S.; Pawson, T.;
Gingras, A. C.; Arrowsmith, C. H.; Knapp, S. Histone recognition and
large-scale structural analysis of the human bromodomain family. Cell
2012, 149 (1), 214−231. (c) Hewings, D. S.; Rooney, T. P. C.; Jennings,
L. E.; Hay, D. A.; Schofield, C. J.; Brennan, P. E.; Knapp, S.; Conway, S. J.
Progress in the development and application of small molecule
inhibitors of bromodomain-acetyl-lysine interactions. J. Med. Chem.
2012, 55 (22), 9393−9413.
(6) Prinjha, R. K.; Witherington, J.; Lee, K. Place your BETs: the
therapeutic potential of bromodomains. Trends Pharmacol. Sci. 2012, 33
(3), 146−153.
(7) Filippakopoulos, P.; Qi, J.; Picaud, S.; Shen, Y.; Smith, W. B.;
Fedorov, O.; Morse, E. M.; Keates, T.; Hickman, T. T.; Felletar, I.;
Philpott, M.; Munro, S.; McKeown, M. R.; Wang, Y. C.; Christie, A. L.;
West, N.; Cameron, M. J.; Schwartz, B.; Heightman, T. D.; La Thangue,
N.; French, C. A.; Wiest, O.; Kung, A. L.; Knapp, S.; Bradner, J. E.
Selective inhibition of BET bromodomains. Nature 2010, 468 (7327),
1067−1073.
(8) French, C. A.; Ramirez, C. L.; Kolmakova, J.; Hickman, T. T.;
Cameron, M. J.; Thyne, M. E.; Kutok, J. L.; Toretsky, J. A.; Tadavarthy,
A. K.; Kees, U. R.; Fletcher, J. A.; Aster, J. C. BRD-NUT oncoproteins: a
family of closely related nuclear proteins that block epithelial
differentiation and maintain the growth of carcinoma cells. Oncogene
2008, 27 (15), 2237−2242.
(9) Qi, J.; Filippakopoulos, P.; Picaud, S.; Smith, W.; Keates, T.; Morse,
E.; Philpott, M.; Shaw, K.; Fedorov, O.; West, N.; Heightman, T.;
French, C.; Knapp, S.; Bradner, J., Small-molecule bromodomain
inhibitors for cancer therapy. Abstr. Pap.Am. Chem. Soc. 2010, 240.
(10) Muller, S.; Filippakopoulos, P.; Knapp, S. Bromodomains as
therapeutic targets. Expert Rev. Mol. Med. 2011, 13, 1−21.
(11) (a) Chung, C. W.; Coste, H.; White, J. H.; Mirguet, O.; Wilde, J.;
Gosmini, R. L.; Delves, C.; Magny, S. M.; Woodward, R.; Hughes, S. A.;
Boursier, E. V.; Flynn, H.; Bouillot, A. M.; Bamborough, P.; Brusq, J. M.
G.; Gellibert, F. J.; Jones, E. J.; Riou, A. M.; Homes, P.; Martin, S. L.;
Uings, I. J.; Toum, J.; Clement, C. A.; Boullay, A. B.; Grimley, R. L.;
Blande, F. M.; Prinjha, R. K.; Lee, K.; Kirilovsky, J.; Nicodeme, E.
Discovery and characterizatlion of small molecule inhibitors of the BET
family bromodomains. J. Med. Chem. 2011, 54 (11), 3827−3838.
(b) Nicodeme, E.; Jeffrey, K. L.; Schaefer, U.; Beinke, S.; Dewell, S.;
Chung, C. W.; Chandwani, R.; Marazzi, I.; Wilson, P.; Coste, H.; White,
J.; Kirilovsky, J.; Rice, C. M.; Lora, J. M.; Prinjha, R. K.; Lee, K.;
Tarakhovsky, A. Suppression of inflammation by a synthetic histone
mimic. Nature 2010, 468 (7327), 1119−1123.
part 2: optimization of phenylisoxazole sulfonamides. J. Med. Chem.
2012, 55 (2), 587−596.
(16) Murray, C. W.; Rees, D. C. The rise of fragment-based drug
discovery. Nat. Chem. 2009, 1 (3), 187−192.
(17) Congreve, M.; Carr, R.; Murray, C.; Jhoti, H. A rule of three for
fragment-based lead discovery? Drug Discovery Today 2003, 8 (19),
876−877.
(18) Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.
Experimental and computational approaches to estimate solubility and
permeability in drug discovery and development settings. Adv. Drug
Delivery Rev. 1997, 23 (1−3), 3−25.
(19) (a) Chen, I. J.; Hubbard, R. E. Lessons for fragment library design:
analysis of output from multiple screening campaigns. J. Comput.-Aided
Mol. Des. 2009, 23 (8), 603−620. (b) Hubbard, R. E.; Davis, B.; Chen, I.;
Drysdale, M. J. The SeeDs approach: integrating fragments into drug
discovery. Curr. Top. Med. Chem. 2007, 7 (16), 1568−1581.
(20) Venhorst, J.; Nunez, S.; Kruse, C. G. Design of a high fragment
efficiency library by molecular graph theory. ACS Med. Chem. Lett. 2010,
1 (9), 499−503.
(21) Weber, L. JChem BaseChemAxon. Chem. World 2008, 5 (10),
65−66.
(22) Scott, D. E.; Coyne, A. G.; Hudson, S. A.; Abell, C. Fragment-
based approaches in drug discovery and chemical biology. Biochemistry
2012, 51 (25), 4990−5003.
(23) Niesen, F. H.; Berglund, H.; Vedadi, M. The use of differential
scanning fluorimetry to detect ligand interactions that promote protein
stability. Nat. Protoc. 2007, 2 (9), 2212−2221.
(24) Mayer, M.; Meyer, B. Characterization of ligand binding by
saturation transfer difference NMR spectroscopy. Angew. Chem., Int. Ed.
1999, 38 (12), 1784−1788.
(25) Dalvit, C.; Fogliatto, G.; Stewart, A.; Veronesi, M.; Stockman, B.
WaterLOGSY as a method for primary NMR screening: practical
aspects and range of applicability. J. Biomol. NMR 2001, 21 (4), 349−
359.
(26) Loria, J. P.; Rance, M.; Palmer, A. G. A relaxation-compensated
Carr−Purcell−Meiboom−Gill sequence for characterizing chemical
exchange by NMR spectroscopy. J. Am. Chem. Soc. 1999, 121 (10),
2331−2332.
(27) Navratilova, I.; Hopkins, A. L. Fragment screening by surface
plasmon resonance. ACS Med. Chem. Lett. 2010, 1 (1), 44−48.
(28) Philpott, M.; Yang, J.; Tumber, T.; Fedorov, O.; Uttarkar, S.;
Filippakopoulos, P.; Picaud, S.; Keates, T.; Felletar, I.; Ciulli, A.; Knapp,
S.; Heightman, T. D. Bromodomain-peptide displacement assays for
interactome mapping and inhibitor discovery. Mol. BioSyst. 2011, 7 (10),
2899−2908.
(29) Caldwell, G. W.; Yan, Z. Y.; Tang, W. M.; Dasgupta, M.; Hasting,
B. ADME optimization and toxicity assessment in early- and late-phase
drug discovery. Curr. Top. Med. Chem. 2009, 9 (11), 965−980.
(30) (a) Sutherland, J. J.; Raymond, J. W.; Stevens, J. L.; Baker, T. K.;
Watson, D. E. Relating molecular properties and in vitro assay results to
in vivo drug disposition and toxicity outcomes. J. Med. Chem. 2012, 55
(14), 6455−6466. (b) Waring, M. J. Defining optimum lipophilicity and
molecular weight ranges for drug candidatesmolecular weight
dependent lower logD limits based on permeability. Bioorg. Med.
Chem. Lett. 2009, 19 (10), 2844−2851. (c) Winiwarter, S.; Bonham, N.
M.; Ax, F.; Hallberg, A.; Lennernas, H.; Karlen, A. Correlation of human
jejunal permeability (in vivo) of drugs with experimentally and
theoretically derived parameters. A multivariate data analysis approach.
J. Med. Chem. 1998, 41 (25), 4939−4949.
(12) Matzuk, M. M.; McKeown, M. R.; Filippakopoulos, P.; Li, Q. L.;
Ma, L.; Agno, J. E.; Lemieux, M. E.; Picaud, S.; Yu, R. N.; Qi, J.; Knapp,
S.; Bradner, J. E. Small-molecule inhibition of BRDT for male
contraception. Cell 2012, 150 (4), 673−684.
(13) Stelow, E. B. A review of NUT midline carcinoma. Head Neck
Pathol 2011, 5 (1), 31−5.
(14) (a) Hewings, D. S.; Wang, M. H.; Philpott, M.; Fedorov, O.;
Uttarkar, S.; Filippakopoulos, P.; Picaud, S.; Vuppusetty, C.; Marsden,
B.; Knapp, S.; Conway, S. J.; Heightman, T. D. 3,5-Dimethylisoxazoles
act as acetyl-lysine-mimetic bromodomain ligands. J. Med. Chem. 2011,
54 (19), 6761−6770. (b) Dawson, M. A.; Prinjha, R. K.; Dittmann, A.;
Giotopoulos, G.; Bantscheff, M.; Chan, W. I.; Robson, S. C.; Chung, C.
W.; Hopf, C.; Savitski, M. M.; Huthmacher, C.; Gudgin, E.; Lugo, D.;
Beinke, S.; Chapman, T. D.; Roberts, E. J.; Soden, P. E.; Auger, K. R.;
Mirguet, O.; Doehner, K.; Delwel, R.; Burnett, A. K.; Jeffrey, P.; Drewes,
G.; Lee, K.; Huntly, B. J. P.; Kouzarides, T. Inhibition of BET
recruitment to chromatin as an effective treatment for MLL-fusion
leukaemia. Nature 2011, 478 (7370), 529−533.
(15) (a) Chung, C. W.; Dean, A. W.; Woolven, J. M.; Bamborough, P.
Fragment-based discovery of bromodomain inhibitors part 1: inhibitor
binding modes and implications for lead discovery. J. Med. Chem. 2012,
55 (2), 576−586. (b) Bamborough, P.; Diallo, H.; Goodacre, J. D.;
Gordon, L.; Lewis, A.; Seal, J. T.; Wilson, D. M.; Woodrow, M. D.;
Chung, C. W. Fragment-based discovery of bromodomain inhibitors
(31) Friesner, R. A.; Murphy, R. B.; Repasky, M. P.; Frye, L. L.;
Greenwood, J. R.; Halgren, T. A.; Sanschagrin, P. C.; Mainz, D. T. Extra
precision glide: docking and scoring incorporating a model of
hydrophobic enclosure for protein−ligand complexes. J. Med. Chem.
2006, 49 (21), 6177−6196.
(32) Halgren, T. A.; Murphy, R. B.; Friesner, R. A.; Beard, H. S.; Frye,
L. L.; Pollard, W. T.; Banks, J. L. Glide: a new approach for rapid,
accurate docking and scoring. 2. Enrichment factors in database
screening. J. Med. Chem. 2004, 47 (7), 1750−1759.
R
dx.doi.org/10.1021/jm301793a | J. Med. Chem. XXXX, XXX, XXX−XXX